FDA Expands Medline Convenience Kit Recall Over Sterility Concern
Medline is correcting convenience kits containing BD ChloraPrep applicators due to a potential breach of sterility, with no serious injuries reported.
4 reports on this incident · first at Sep 2, 2026, 7:11 p.m. ET
Earlier reports
Sep 2, 2026, 7:21 p.m. ET
FDA Reclassifies Medline Convenience Kit Recall as Class II
The U.S. Food and Drug Administration has reclassified the Medline convenience kit correction as a Class II recall, according to an FDA notice dated September 2, 2026. The agency did not specify the previous classification in the notice.
The correction applies to convenience kits containing BD ChloraPrep applicators. The kits contain various surgical instruments, dressings and/or other materials, and pharmaceutical components intended for use during surgical procedures. The reason for the correction is a potential breach of sterility in the packaging due to wrinkles in the paper lidding that may extend to the seal area, or an open or incomplete seal on the applicator packaging.
If the sterile barrier is compromised, patients and users may be exposed to microbial contamination, with potential health consequences ranging from no injury to localized infection or, less commonly, more serious infection requiring medical treatment, antimicrobial therapy, procedural intervention, or hospitalization. As of August 3, Medline has reported no serious injuries or deaths associated with this issue.
The FDA instructs users to remove affected BD ChloraPrep applicators and apply over-labels to all affected kits on hand stating that the affected components must be removed and discarded prior to use.
Sep 2, 2026, 7:15 p.m. ET
FDA Reports No Serious Injuries or Deaths in Medline Convenience Kit Recall
As of August 3, Medline has reported no serious injuries or deaths associated with a potential sterility issue in certain convenience kits, the U.S. Food and Drug Administration (FDA) announced on September 2, 2026.
The FDA classified the action as a Class II recall. The affected convenience kits contain various surgical instruments, dressings and/or other materials, and pharmaceutical components intended for use during surgical procedures. The reason for the correction is a potential breach of sterility in the packaging, due to wrinkles in the paper lidding which may extend to the seal area, or the affected product may exhibit an open or incomplete seal on the packaging of the applicator.
If the sterile barrier is compromised, patients and users may be exposed to microbial contamination. Potential health consequences may include no injury, localized infection, or, less commonly, more serious infection requiring medical treatment, antimicrobial therapy, procedural intervention, or hospitalization.
Medline has instructed users to remove affected BD ChloraPrep applicators and apply over-labels to all affected kits on hand stating that the affected components must be removed and discarded prior to use.
Sep 2, 2026, 7:11 p.m. ETFirst report
Medline Recalls Convenience Kits Over Sterility Concern
Medline has issued a correction for convenience kits containing BD ChloraPrep applicators, the U.S. Food and Drug Administration (FDA) announced on September 2, 2026. The recall is classified as Class II, according to the FDA.
The reason for the correction is a potential breach of sterility in the packaging, due to wrinkles in the paper lidding that may extend to the seal area, or the affected product may exhibit an open or incomplete seal on the packaging of the applicator, the FDA reported. If the sterile barrier is compromised, patients and users may be exposed to microbial contamination, with potential health consequences ranging from no injury to localized infection or, less commonly, more serious infection requiring medical treatment, antimicrobial therapy, procedural intervention, or hospitalization.
As of August 3, Medline has reported no serious injuries or deaths associated with this issue, according to the FDA. The convenience kits contain various surgical instruments, dressings and/or other materials, and pharmaceutical components intended for use during various surgical procedures.
The FDA instructs users to remove affected BD ChloraPrep applicators and apply over-labels to all affected kits on hand stating that the affected components must be removed and discarded prior to use.
Was this report accurate and useful?
Sources
Revision history
- Version 12 Sept 2026, 23:22current
First published.
- Version 12 Sept 2026, 23:11current
First published.
- Version 12 Sept 2026, 23:15current
First published.
- Version 12 Sept 2026, 23:21current
First published.
How we work
This site models an investigative reporter rather than a wire desk. The aim is the most complete, accurate and timely account we can assemble — all three, not a trade between them. Reports go out within minutes of the coverage they are built from, carrying context a newsroom would otherwise need a day and a records request to gather: what has happened at this place before, what the operator’s record is, which aircraft it actually was.
Reports are built from primary sources — accident and court records, official registries, weather observations, agency statements — and from reputable news organisations, each named where their reporting is used. Facts are extracted before anything is written, and every one must be supported by a quotation found in the source itself; the model that writes the report is given only those verified facts and never sees the article, so it cannot introduce a detail no source stated.
Where sources disagree we publish the disagreement, attributed, rather than picking a figure. Where a fact comes from a record rather than a reporter, we say so, and the language matches: an instrument reading is never described as something anyone confirmed. Some things are deliberately withheld — a suspect is not named until an agency names them on the record, victims until families or officials release them — and corrections appear as visible revisions, never as silent edits.
None of that makes a report true. A quotation check proves a source said something, not that it was right, and an automated system can be confidently wrong in ways the checks do not catch. If something here is wrong, the feedback above is how it gets found. The full methodology, including what we refuse to publish.